Allium introduces first-ever Bladder-Neck Stent

Removable stent provides viable solution to patients recovering from complications of bladder and prostate cancer operations

CAESAREA, Israel – February 3, 2009 - (HSMN NewsFeed) - Allium Group, the developer and manufacturer of innovative stents for the urinary, gastro-intestinal, pulmonary and peripheral vascular tracts, announced today that it has been awarded a CE mark for its large caliber, removable posterior urethral stent. This is a novel solution for patients who developed a stenosis at the bladder neck after radical removal of the prostate or the bladder for cancer.

“As the fourth stent to receive a CE Mark, Allium’s technology is rapidly gaining an established presence throughout Europe as more hospitals and physicians discover the significant advantages of using removable stents as an effective solution,” said Limor Domnitz Gishri, CEO of Allium Medical. “Allium is at the forefront of the expanding stent industry, developing the only next generation stents designed to fit site specific areas in the urinary and gastro-intestinal tracts. Allium’s goal is to provide the global medical market with the tools to enhance patient treatment, comfort and quality of life with a minimally invasive approach."

Full text >>